Publications and Media Releases

Explore our latest research, peer-reviewed publications, and official press announcements.

16 Results

  • Featured

    Journal of Digital Health — QA Test

    Sample Study: Digital Tools and Patient Outcomes

    This sample publication explores how digital health tools can support patient monitoring, improve access to information, and help healthcare teams review patient-reported outcomes.

    Key finding

    Digital tools may support consistent tracking and communication when appropriately designed and implemented.

  • Featured

    NXTSTIM Releases 24-Month Real-World Data on EcoAI, Its FDA-Cleared Non-Invasive Neuromodulation Platform (September 2025)

    Landmark 24-month study of over 2,100 patients shows EcoAI™ delivers long-term pain relief and functional improvement with zero adverse events.

    Key finding

    a. 187,930 self-administered sessions across 2,100 adults with chronic pain. b. Median pain scores dropped from 4.1 at baseline to 1.9 after 24 months. c. Responder rates (patients with stable or improved symptoms) ranged between 66% and 71%, sustained over two years. d. Quality-of-life metrics: mood, function, social engagement, work activity, improved significantly (p < 0.01). e. Optimal use: 2 - 4 sessions daily, 20 - 59 minutes each; older adults (≥60) showed the highest compliance and benefit. f. Zero adverse events reported in nearly 188,000 sessions, underscoring EcoAI’s safety in home-based use.

  • Clinical Technology Review — QA Test

    Sample Research: Patient Monitoring Technology

    This sample record describes the potential use of digital technology to organize patient monitoring information.

    Key finding

    Digital records can help organize information for review.

  • Adaptive dual-modality neuromodulation for chronic pain and muscle dysfunction: real-world insights from the NXTSTIM™ EcoAI digital platform

    EcoAI, an AI-guided TENS+EMS platform, significantly improved muscle weakness, fatigue, and spasms, with greater pain reduction in users who adhered more consistently. It demonstrated strong safety with no device-related adverse events, supporting its effectiveness as a real-world neuromuscular and pain management solution.

  • AI and Remote Monitoring in Pain Management: Clinical Progress and Policy Imperatives

    AI and remote monitoring can fundamentally shift chronic pain care away from reactive, opioid-dependent models toward personalized, data-driven relief. This editorial covers real-world clinical outcomes, Remote Therapeutic Monitoring (RTM) reimbursement codes, and the policy steps needed to scale these innovations equitably.

Want to stay in the loop or get in touch?

Follow us on social media for real-time updates or reach out directly to start a conversation with the NXTSTIM team.